Skip to main content

Animations

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2482${count})

  • Research Grant, 2016
    Electrical Stimulation of the Brain as Parkinson's Disease Treatment

    Study Rationale:
    Depression is a common non-motor symptom associated with Parkinson's disease (PD), and impulse control disorders (ICDs) are behaviors that may arise with use of certain PD medications...

  • Research Grant, 2016
    Registry for the Advancement of Deep Brain Stimulation Therapy in Parkinson's Disease (RAD-PD)

    Study Rationale:
    Deep brain stimulation (DBS) is a surgical treatment for Parkinson's disease (PD) that may benefit those who experience motor complications, such as "off" periods and/or dyskinesia...

  • Access to Data and Biospecimens, 2016
    MicroRNAs as biomarkers of the prodromal stage of Parkinson disease’

    Study Rationale:

    MicroRNAs (miRNAs) are small regulatory RNAs controlling gene expression. We have recently reported reduced  miRNAs levels in serum from Parkinson disease (PD) patients, and also from...

  • Research Grant, 2016
    Study of Alpha-synuclein in the Dorsal Neostriatum

    Promising Outcomes of Original Grant:
    In February 2013, Luk et al. published in Science that administration of synthetic alpha-synuclein into pre-formed fibrils in pre-clinical models was sufficient to...

  • Therapeutic Pipeline Program, 2016
    Effect of HDAC Inhibition in Models of Parkinson's Disease

    Study Rationale:
    Numerous publications have linked the family of epigenetic enzymes known as HDACs (histone deactylases) to the underlying pathology of Parkinson's. This study will test the efficacy of...

  • Therapeutic Pipeline Program, 2016
    Cognitive Behavioral Therapy for Anxiety Disorders in Parkinson's Disease

    Study Rationale:
    Anxiety disorders occur in up to 35 percent of people with Parkinson's disease and can have a negative impact on gait, involuntary movements, motor fluctuations and quality of life...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.